Retroviral vectors for gene transfer

Cold Spring Harbor Protocols

Volumn 3, Issue 4, 2008, Pages

  Cornetta, Kenneth ^a   Pollok, Karen E ^a   Miller, A Dusty ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC RNA; RETROVIRUS VECTOR; VIRUS RNA;

ARTICLE; CELL LINE; GENE TRANSFER; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HEMATOPOIETIC CELL; HUMAN; MOLONEY LEUKEMIA ONCOVIRUS; MUTAGENESIS; NONHUMAN; SEQUENCE ANALYSIS; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRAL GENETICS; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME;

EID: 44949100169     PISSN: None     EISSN: 15596095     Source Type: Journal    
DOI: 10.1101/pdb.top29     Document Type: Article

References (25)

1. Berns, A. 2004. Good news for gene therapy. N. Engl. J. Med. 350: 1679-1680.
2. Cavazzana-Calvo, M., Hacein-Bey, S., de Saint Basile, G., Gross, F., Yvon, E., Nusbaum, P., Selz, F., Hue, C., Certain, S., Casanova, J.L., et al. 2000. Gene therapy of human severe combined immunodeficiency (SCID)X1 disease. Science 288: 669-672.
3. Challita, P.M. and Kohn, D.B. 1994. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc. Natl. Acad. Sci. 91: 2567-2571.
4. Cornetta, K. 1992. Safety aspects of gene therapy. Br. J. Haematol. 80: 421-426.
5. Cornetta, K., Nguyen, N., Morgan, R.A., Muenchau, D.D., Hartley, J.W., Blaese, R.M., and Anderson, W.F. 1993. Infection of human cells with murine amphotropic replication-competent retroviruses. Hum. Gene Ther. 4: 579-588.
6. Cosset, F.L., Takeuchi, Y., Battini, J.L., Weiss, R.A., and Collins, M.K. 1995. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69: 7430-7436.
7. Dave, U.P., Jenkins, N.A., and Copeland, N.G. 2004. Gene therapy insertional mutagenesis insights. Science 303: 333.
8. Donahue, R.E., Kessler, S.W., Bodine, D., McDonagh, K., Dunbar, C., Goodman, S., Agricola, B., Byrne, E., Raffeld, M., Moen, R., et al. 1992. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J. Exp. Med. 176: 1125-1135.
9. Forestell, S.P., Dando, J.S., Chen, J., de Vries, P., Bohnlein, E., and Rigg, R.J. 1997. Novel retroviral packaging cell lines: Complementary tropisms and improved vector production for efficient gene transfer. Gene Ther. 4: 600-610.
10. Hacein-Bey-Abina, S., Le Deist, F., Carlier, F., Bouneaud, C., Hue, C., De Villartay, J.P., Thrasher, A.J., Wulffraat, N., Sorensen, R., Dupuis-Girod, S., et al. 2002. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N. Engl. J. Med. 346: 1185-1193.
11. Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., Le Deist, F., Wulffraat, N., McIntyre, E., Radford, I., Villeval, J.L., Fraser, C.C., Cavazzana-Calvo, M., et al. 2003a. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348: 255-256.
12. Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M.P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C.S., Pawliuk, R., Morillon, E., et al. 2003b. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302: 415-419.
13. Hawley, R.G. 2001. Progress toward vector design for hematopoietic stem cell gene therapy. Curr. Gene Ther. 1:1-17.
14. Jahner, D., Stuhlmann, H., Stewart, C.L., Harbers, K., Lohler, J., Simon, I., and Jaenisch, R. 1982. De novo methylation and expression of retroviral genomes during mouse embryogenesis. Nature 298: 623-628.
15. Kraunus, J., Schaumann, D.H., Meyer, J., Modlich, U., Fehse, B., Brandenburg, G., von Laer, D., Klump, H., Schambach, A., Bohne, J., et al. 2004. Self-inactivating retroviral vectors with improved RNA processing. Gene Ther. 11: 1568-1578.
16. Li, Z., Dullmann, J., Schiedlmeier, B., Schmidt, M., von Kalle, C., Meyer, J., Forster, M., Stocking, C., Wahlers, A., Frank, O., et al. 2002. Murine leukemia induced by retroviral gene marking. Science 297: 497.
17. Mann, R., Mulligan, R.C., and Baltimore, D. 1983. Construction of a retrovirus packaging mutant and its use to produce helperfree defective retrovirus. Cell 33: 153-159.
18. Markowitz, D., Goff, S., and Bank, A. 1988. A safe packaging line for gene transfer: Separating viral genes on two different plasmids. J. Virol. 62: 1120-1124.
19. Miller, A.D. and Buttimore, C. 1986. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol 6: 2895-2902.
20. Miller, A.D. and Chen, F. 1996. Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry. J. Virol. 70: 5564-5571.
21. Miller, A.D. and Rosman, G.J. 1989. Improved retroviral vectors for gene transfer and expression.Biotechniques 7: 980-990.
22. Miller, A.D., Garcia, J.V., von Suhr, N., Lynch, C.M., Wilson, C., and Eiden, M.V. 1991. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 65: 2220-2224.
23. Overbaugh, J., Miller, A.D., and Eiden, M.V. 2001. Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycosylphosphatidylinositolanchored and secreted proteins. Microbiol. Mol. Biol. Rev. 65: 371-389.
24. Pannell, D. and Ellis, J. 2001. Silencing of gene expression: Implications for design of retrovirus vectors. Rev. Med. Virol. 11: 205-217.
25. Watanabe, S. and Temin, H.M. 1983. Construction of a helper cell line for avian reticuloendotheliosis virus cloning vectors. Mol. Cell. Biol. 3: 2241-2249.